Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    March 2018
  1. CHATTERJEE S, Khunti K, Davies MJ
    Type 2 diabetes - Authors' reply.
    Lancet. 2018;391:1262.
    PubMed     Text format    


  2. TATE AR
    Type 2 diabetes.
    Lancet. 2018;391:1261-1262.
    PubMed     Text format    


  3. BOUSSAGEON R, Roustit M, Gueyffier F, Tudrej BV, et al
    Type 2 diabetes.
    Lancet. 2018;391:1261.
    PubMed     Text format    


    February 2018
  4. BHATT DL
    CABG the clear choice for patients with diabetes and multivessel disease.
    Lancet. 2018 Feb 22. pii: S0140-6736(18)30424.
    PubMed     Text format    


  5. SARHAN MB, Ghandour R, Rmeileh NMEA
    The effectiveness of counselling interventions in reducing HbA1c concentrations in patients with type 2 diabetes: a modelling study.
    Lancet. 2018;391 Suppl 2:S30.
    PubMed     Text format     Abstract available


  6. SAMAN KA, Massad S, Ibaid AA, Anan H, et al
    Factors associated with depression in patients with type 2 diabetes in the Gaza Strip: a cross sectional study.
    Lancet. 2018;391 Suppl 2:S19.
    PubMed     Text format     Abstract available


  7. CANALI G, Tittle V, Seita A
    Medication adherence by Palestine refugees living in Jordan who have diabetes: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S13.
    PubMed     Text format     Abstract available


  8. BERGENSTAL RM
    Continuous glucose monitoring: transforming diabetes management step by step.
    Lancet. 2018 Feb 15. pii: S0140-6736(18)30290.
    PubMed     Text format    


  9. HEINEMANN L, Freckmann G, Ehrmann D, Faber-Heinemann G, et al
    Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Lancet. 2018 Feb 15. pii: S0140-6736(18)30297.
    PubMed     Text format     Abstract available


    December 2017
  10. UUSITUPA M
    Remission of type 2 diabetes: mission not impossible.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33100.
    PubMed     Text format    


  11. LEAN ME, Leslie WS, Barnes AC, Brosnahan N, et al
    Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33102.
    PubMed     Text format     Abstract available


    November 2017
  12. BROWN DM, Wykoff CC
    Intravitreal aflibercept for proliferative diabetic retinopathy.
    Lancet. 2017;390:2141.
    PubMed     Text format    


  13. SIVAPRASAD S, Prevost AT, Vasconcelos J, Riddell A, et al
    Intravitreal aflibercept for proliferative diabetic retinopathy - Authors' reply.
    Lancet. 2017;390:2141-2142.
    PubMed     Text format    


  14. LIU L, Tham YC, Cheng CY
    Intravitreal aflibercept for proliferative diabetic retinopathy.
    Lancet. 2017;390:2140-2141.
    PubMed     Text format    


    October 2017
  15. MCGAVOCK J, Wicklow B, Dart AB
    Type 2 diabetes in youth is a disease of poverty.
    Lancet. 2017;390:1829.
    PubMed     Text format    


    September 2017
  16. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    PubMed     Text format    


  17. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    PubMed     Text format     Abstract available


  18. JEFFCOATE W, Barron E, Lomas J, Valabhji J, et al
    Using data to tackle the burden of amputation in diabetes.
    Lancet. 2017 Sep 11. pii: S0140-6736(17)32401.
    PubMed     Text format    


    June 2017
  19. VINER R, White B, Christie D
    Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden.
    Lancet. 2017;389:2252-2260.
    PubMed     Text format     Abstract available


  20. FORSTER DA, Moorhead AM, Jacobs SE, Davis PG, et al
    Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial.
    Lancet. 2017;389:2204-2213.
    PubMed     Text format     Abstract available


  21. LANE R
    Elizabeth Mayer-Davis: leader in adolescent diabetes.
    Lancet. 2017;389:2184.
    PubMed     Text format    


  22. BERENS P
    Antenatal milk expression for women with diabetes in pregnancy.
    Lancet. 2017;389:2167-2168.
    PubMed     Text format    


  23. THE LANCET
    Diabetes: a dynamic disease.
    Lancet. 2017;389:2163.
    PubMed     Text format    


  24. LIAPIS K, Vlachou S, Markou A, Kakiopoulos G, et al
    As white as ivory: sclerotic vertebra in POEMS syndrome.
    Lancet. 2017;389:2261-2262.
    PubMed     Text format    


    May 2017
  25. TING DSW, Wong TY
    Proliferative diabetic retinopathy: laser or eye injection?
    Lancet. 2017 May 5. pii: S0140-6736(17)31194.
    PubMed     Text format    


  26. SIVAPRASAD S, Prevost AT, Vasconcelos JC, Riddell A, et al
    Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2
    Lancet. 2017 May 5. pii: S0140-6736(17)31193.
    PubMed     Text format     Abstract available


    March 2017
  27. MENDENHALL E, Kohrt BA, Norris SA, Ndetei D, et al
    Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.
    Lancet. 2017;389:951-963.
    PubMed     Text format     Abstract available


  28. REGMI PR, Alloh F, Pant PR, Simkhada P, et al
    Mental health in BME groups with diabetes: an overlooked issue?
    Lancet. 2017;389:904-905.
    PubMed     Text format    


    February 2017
  29. LE ROUX CW, Astrup A, Fujioka K, Greenway F, et al
    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    Lancet. 2017 Feb 22. pii: S0140-6736(17)30069.
    PubMed     Text format     Abstract available


  30. CHATTERJEE S, Khunti K, Davies MJ
    Type 2 diabetes.
    Lancet. 2017 Feb 9. pii: S0140-6736(17)30058.
    PubMed     Text format     Abstract available


    January 2017
  31. THE LANCET
    Obesity and diabetes in 2017: a new year.
    Lancet. 2017;389:1.
    PubMed     Text format    


    December 2016
  32. EL-KHATIB FH, Balliro C, Hillard MA, Magyar KL, et al
    Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    Lancet. 2016 Dec 20. pii: S0140-6736(16)32567.
    PubMed     Text format     Abstract available


    November 2016

  33. Reversing the rising tide of diabetes in China.
    Lancet. 2016;388:2566.
    PubMed     Text format    


    October 2016
  34. GREEN A
    NIH project focuses on integration of HIV and NCD care.
    Lancet. 2016;388:1869.
    PubMed     Text format    


  35. CHENG L, Sit JW, Choi K, Li X, et al
    Efficacy of the Diabetes Empowerment Self-management Interactive Research (DESIRE) programme in Chinese patients with poorly controlled type 2 diabetes: a randomised controlled trial.
    Lancet. 2016;388 Suppl 1:S9.
    PubMed     Text format     Abstract available


    September 2016
  36. DING D, Lawson KD, Kolbe-Alexander TL, Finkelstein EA, et al
    The economic burden of physical inactivity: a global analysis of major non-communicable diseases.
    Lancet. 2016;388:1311-24.
    PubMed     Text format     Abstract available


  37. THE LANCET
    Balancing the benefits and risks of choice.
    Lancet. 2016;388:1129.
    PubMed     Text format    


  38. BOLINDER J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, et al
    Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
    Lancet. 2016 Sep 9. pii: S0140-6736(16)31535.
    PubMed     Text format     Abstract available


    August 2016
  39. WALLENTIN L, Lindhagen L, Arnstrom E, Husted S, et al
    Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31276.
    PubMed     Text format     Abstract available



  40. NHS England: preparing for PrEP.
    Lancet. 2016;388:634.
    PubMed     Text format    


  41. MACDONALD GC, Campbell LV
    Mental illness: the forgotten burden on diabetes populations?
    Lancet. 2016;388:561.
    PubMed     Text format    


    July 2016
  42. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available


    June 2016
  43. REWERS M, Ludvigsson J
    Environmental risk factors for type 1 diabetes.
    Lancet. 2016;387:2340-8.
    PubMed     Text format     Abstract available


  44. POCIOT F, Lernmark A
    Genetic risk factors for type 1 diabetes.
    Lancet. 2016;387:2331-9.
    PubMed     Text format     Abstract available


  45. RUBIN R
    Kevan Herold: untangling type 1 diabetes in the clinic and the lab.
    Lancet. 2016;387:2283.
    PubMed     Text format    


  46. RUBIN R
    Profile: Type 1 Diabetes TrialNet.
    Lancet. 2016;387:2280.
    PubMed     Text format    



  47. Towards a better understanding of type 1 diabetes.
    Lancet. 2016;387:2264.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: